Fig. 2From: ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancerDistribution of ANLN nuclear fraction. Distribution of ANLN nuclear fraction was analyzed in two independent breast cancer cohorts. The majority of tumors investigated expressed less than 25% of ANLN nuclear stainingBack to article page